Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business announced a strategic investment in PHS Technologies Group, LLC, a division of PACSHealth, LLC, to further expand its portfolio of Informatics Solutions for Radiology.
The strategic investment is aimed at broadening Bracco’s portfolio of software applications for dose management in order to provide healthcare organizations with the information needed to ensure patient safety, enhance imaging exam consistency, maintain regulatory compliance and monitor radiation dose at an enterprise level.
The agreement strengthens the partnership with PHS Technologies Group, allowing Bracco to enhance distribution efforts of NEXO[DOSE]® in existing markets and access emerging opportunities in new geographies.“We are pleased to reinforce our partnership with PHS Technologies” said Fulvio Renoldi Bracco, Head of the Business Unit Imaging at Bracco Imaging. “The investment will provide new opportunities for Bracco to quickly address the increasing challenges in healthcare delivery according to the new market requirements in terms of radiation exposure monitoring.”
“PHS Technologies Group is excited to expand its relationship with Bracco” said Mike Battin, Chief Operating Officer of PHS Technologies Group. “PHS is the OEM manufacturer for Bracco’s product and will implement an expanded service and support offerings to the new markets. Furthermore PHS will provide significant functional improvements to the application portfolio over the next 24 months.”
About NEXO [DOSE]®
is a software application for automated patient radiation exposure data aggregation and reporting from multiple x-ray modalities. It provides healthcare facilities of all sizes enterprisewide visibility from day one into patient radiation dose exposure, thus allowing end user to capture, analyze and act upon critical information. Thanks to its zero desktop footprint and vendor-neutral software, NEXO[DOSE]® is easy to install, implement and use.
About Bracco Imaging
Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops,manufactures and markets diagnostic imaging agents and solutions that meet medical needs. Bracco Imaging offers a product and solution portfolio for all key diagnostic imaging modalities: Xray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS),Nuclear Medicine through radioactive tracers. The diagnostic imaging offer is completed by several medical devices and advanced administration systems for contrast imaging products in the fields of radiology.
The Company operates in more than 100 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements. With an on-going research covering all key modalities, Bracco Imaging has a strong presence in key geographies: North America, Europe and Japan operating through the Joint Venture Bracco-Eisai Co. Ltd. The Company also operates in Brazil, South Korea, and China through the Joint Venture Bracco Sine Pharmaceutical Corp. Ltd. Operational investments have been made in order to achieve top quality and compliances with a sustainable eco-friendly production.
Manufacturing activities are located in Italy, Switzerland, Japan, China, and Germany. Bracco Imaging is an innovative Research and Development (R&D) player with an efficient process oriented approach and a track record of innovation in the diagnostic imaging industry. R&D activities are managed in the three Research
Centres located in Italy, Switzerland, and USA.To learn more about Bracco Imaging, visit www.braccoimaging.com .
About PHS Technologies Group LLC
PHS Technologies Group, LLC is a division of PACSHealth, LLC, a medical software development company based in Scottsdale, AZ, that develops software systems for medical imaging technology.PHS Technologies Group is committed to helping the medical community reduce patient exposure to ionizing radiation through advanced solutions that enable hospitals to manage patient radiation exposure and comply with regulatory requirements and industry guidelines while increasing efficiency and reducing cost.
For more information about DoseMonitor,
please visit www.dosemonitor.com
Battin (877) 877-1457 x802;